Eagle Pharmaceuticals
EGRX
#8886
Rank
C$75.05 M
Marketcap
$5.79
Share price
-0.23%
Change (1 day)
-71.87%
Change (1 year)

Earnings for Eagle Pharmaceuticals (EGRX)

Earnings in 2023 (TTM): C$47.93 M

According to Eagle Pharmaceuticals 's latest financial reports the company's current earnings (TTM) are C$48.36 M. In 2022 the company made an earning of C$89.35 M an increase over its 2021 earnings that were of -C$3.96 M.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eagle Pharmaceuticals from 2013 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) C$47.93 M-46.35%
2022 C$89.35 M-2361.45%
2021 -C$3.96 M-111.53%
2020 C$34.25 M2.31%
2019 C$33.48 M-32.89%
2018 C$49.88 M-50.35%
2017 C$0.10 B38.63%
2016 C$72.48 M1966.43%
2015 C$3.5 M-111.46%
2014 -C$30.62 M282.82%
2013 -C$8 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
C$27.49 B 56,752.41%๐Ÿ‡บ๐Ÿ‡ธ USA
C$8.50 B 17,482.38%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$14.78 B 30,464.51%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
C$1.12 B 2,219.19%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
C$4.78 B 9,785.30%๐Ÿ‡บ๐Ÿ‡ธ USA
C$12.19 B 25,109.06%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$8.71 B-18,101.07%๐Ÿ‡บ๐Ÿ‡ธ USA